LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 72.52 | 84.90 | 6596 | 9214 | 0.7158 | 0.9035 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 72.52 | 84.90 | 709 | 9214 | 0.0769 | 0.3687 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 72.52 | 84.90 | 8294 | 9214 | 0.9001 | 0.9691 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 74.22 | 84.90 | 1508 | 9343 | 0.1614 | 0.5284 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 74.22 | 84.90 | 6663 | 9343 | 0.7131 | 0.9027 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 74.22 | 84.90 | 617 | 9343 | 0.0660 | 0.3397 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 74.22 | 84.90 | 8440 | 9343 | 0.9033 | 0.9702 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 75.93 | 84.90 | 1644 | 8970 | 0.1833 | 0.5539 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 75.93 | 84.90 | 6935 | 8970 | 0.7731 | 0.9249 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 75.93 | 84.90 | 657 | 8970 | 0.0732 | 0.3557 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 75.93 | 84.90 | 8648 | 8970 | 0.9640 | 0.9891 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 77.64 | 84.90 | 1649 | 9245 | 0.1784 | 0.5502 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 77.64 | 84.90 | 7132 | 9245 | 0.7714 | 0.9247 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 77.64 | 84.90 | 672 | 9245 | 0.0727 | 0.3576 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 77.64 | 84.90 | 8853 | 9245 | 0.9575 | 0.9872 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 79.34 | 84.90 | 1644 | 9051 | 0.1816 | 0.5526 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 79.34 | 84.90 | 7325 | 9051 | 0.8093 | 0.9381 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 79.34 | 84.90 | 679 | 9051 | 0.0750 | 0.3616 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 79.34 | 84.90 | 9105 | 9051 | 1.0059 | 1.0017 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 81.05 | 84.90 | 1766 | 8863 | 0.1992 | 0.5724 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 81.05 | 84.90 | 7548 | 8863 | 0.8515 | 0.9526 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 81.05 | 84.90 | 619 | 8863 | 0.0698 | 0.3448 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 81.05 | 84.90 | 9314 | 8863 | 1.0508 | 1.0148 | MN20160318_Q02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 82.75 | 84.90 | 1873 | 8621 | 0.2173 | 0.5906 | MN20160318_Q02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 82.75 | 84.90 | 7779 | 8621 | 0.9023 | 0.9694 | MN20160318_Q02 | E16 |